MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
BACKGROUND: MicroRNAs are small non-coding RNA molecules, which regulate central mechanisms of tumorigenesis. In colorectal tumours, the combination of gain of 8q and 13q is one of the major factors associated with colorectal adenoma to adenocarcinoma progression. Functional studies on the miR-17-92 cluster localised on 13q31 have shown that its transcription is activated by c-myc, located on 8q, and that it has oncogenic activities. We investigated the contribution of the miR-17-92 cluster during colorectal adenoma to adenocarcinoma progression. METHODS: Expression levels of the miR-17-92 cluster were determined in 55 colorectal tumours and in 10 controls by real-time RT-PCR. Messenger RNA c-myc expression was also determined by real-time RT-PCR in 48 tumours with array comparative genomic hybridisation (aCGH) data available. RESULTS: From the six members of the miR-17-92 cluster, all except miR-18a, showed significant increased expression in colorectal tumours with miR-17-92 locus gain compared with tumours without miR-17-92 locus gain. Unsupervised cluster analysis clustered the tumours based on the presence of miR-17-92 locus gain. Significant correlation between the expression of c-myc and the six miRNAs was also found. CONCLUSION: Increased expression of miR-17-92 cluster during colorectal adenoma to adenocarcinoma progression is associated to DNA copy number gain of miR17-92 locus on 13q31 and c-myc expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993) · Cell · doi:10.1016/0092-8674(93)90529-y · Cited by 12,948 · cited 1×
“…central pathways to cellular homoestasis, development and tumorigenesis, including proliferation, apoptosis, differentiation, maintenance of stem cell potency and angiogenesis (Lee et al, 1993; Wightman et al, 1993; Reinhart et al, 2000; Brennecke et al, 2003; Chen et al, 2004; Zhao et al, 2007).”
BackgroundA genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
A microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697
Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242606799 · Cited by 5,111 · cited 1×
“…et al, 2004) and miRNA expression changes have been found to be associated with chromosomal rearrangements in ovarian cancer, breast cancer, lung cancer, melanomas and hematopoietic malignancies (Calin et al, 2002; Hayashita et al, 2005; Lu et al, 2005; Zhang et al, 2006; Tagawa et al, 2007).”
Wightman, B., Ha, I., & Ruvkun, G. (1993) · Cell · doi:10.1016/0092-8674(93)90530-4 · Cited by 4,292 · cited 1×
“…central pathways to cellular homoestasis, development and tumorigenesis, including proliferation, apoptosis, differentiation, maintenance of stem cell potency and angiogenesis (Lee et al, 1993; Wightman et al, 1993; Reinhart et al, 2000; Brennecke et al, 2003; Chen et al, 2004; Zhao et al, 2007).”
BackgroundSilencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949 · cited 1×
“…that is, the down stream targets, through which the miR-17-92 miRNAs contribute to colorectal adenoma progression have not been identified yet, it is tempting to speculate on the possibility of using antagomiRs to interfere with colorectal adenoma to carcinoma progression (Krutzfeldt et al, 2005).”
BackgroundMicroRNAs Modulate Hematopoietic Lineage Differentiation
Chen, C.-Z., Li, L., Lodish, H. F., & Bartel, D. P. (2004) · Science · doi:10.1126/science.1091903 · Cited by 3,257 · cited 1×
“…central pathways to cellular homoestasis, development and tumorigenesis, including proliferation, apoptosis, differentiation, maintenance of stem cell potency and angiogenesis (Lee et al, 1993; Wightman et al, 1993; Reinhart et al, 2000; Brennecke et al, 2003; Chen et al, 2004; Zhao et al, 2007).”
BackgroundBrennecke, J., Hipfner, D. R., Stark, A., Russell, R. B., & Cohen, S. M. (2003) · Cell · doi:10.1016/s0092-8674(03)00231-9 · Cited by 2,042 · cited 1×
“…central pathways to cellular homoestasis, development and tumorigenesis, including proliferation, apoptosis, differentiation, maintenance of stem cell potency and angiogenesis (Lee et al, 1993; Wightman et al, 1993; Reinhart et al, 2000; Brennecke et al, 2003; Chen et al, 2004; Zhao et al, 2007).”
BackgroundMicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression
Ivanovska, I., Ball, A. S., Diaz, R. L., Magnus, J. F., Kibukawa, M., Schelter, J. M., Kobayashi, S. V., Lim, L., Burchard, J., Jackson, A. L., et al. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01977-07 · Cited by 561
Cited by
Targeting microRNAs in cancer: rationale, strategies and challenges
Garzon, R., Marcucci, G., & Croce, C. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3179 · Cited by 1,493
Mogilyansky, E., & Rigoutsos, I. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2013.125 · Cited by 889
Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer
Matsumura, T., Sugimachi, K., Iinuma, H., Takahashi, Y., Kurashige, J., Sawada, G., Ueda, M., Uchi, R., Ueo, H., Takano, Y., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.201 · Cited by 453
Portrait of the PI3K/AKT pathway in colorectal cancer
Danielsen, S. A., Eide, P. W., Nesbakken, A., Guren, T., Leithe, E., & Lothe, R. A. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.09.008 · Cited by 321
Wu, C. W., Ng, S. S. M., Dong, Y. J., Ng, S. C., Leung, W. W., Lee, C. W., Wong, Y. N., Chan, F. K. L., Yu, J., & Sung, J. J. Y. (2012) · Gut · doi:10.1136/gut.2011.239236 · Cited by 275
“A recent study has shown that chromosomal copy number gain at the miR17-92 cluster region (miR-92a is located at this region) was associated with the neoplastic progression from adenoma to adenocarcinoma.(30) This observation may partly explain the higher expression of stool-based miR-92a in stools of patients with pr…”
BackgroundCirculating biomarkers for early detection and clinical management of colorectal cancer
Marcuello, M., Vymetalkova, V., Neves, R. P. L., Duran-Sanchon, S., Vedeld, H. M., Tham, E., van Dalum, G., Flügen, G., Garcia-Barberan, V., Fijneman, R. J., et al. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.06.002 · Cited by 275
Dews, M., Fox, J. L., Hultine, S., Sundaram, P., Wang, W., Liu, Y. Y., Furth, E., Enders, G. H., El-Deiry, W., Schelter, J. M., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2412 · Cited by 268
MYC Oncogene Contributions to Release of Cell Cycle Brakes
García-Gutiérrez, L., Delgado, M. D., & León, J. (2019) · Genes · doi:10.3390/genes10030244 · Cited by 255
The role of microRNAs in colorectal cancer
Schetter, A. J., Okayama, H., & Harris, C. C. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e318258b78f · Cited by 252
miR‐92 is a key oncogenic component of the miR‐17–92 cluster in colon cancer
Tsuchida, A., Ohno, S., Wu, W., Borjigin, N., Fujita, K., Aoki, T., Ueda, S., Takanashi, M., & Kuroda, M. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02081.x · Cited by 243
Tumor suppressor p53 meets microRNAs
Feng, Z., Zhang, C., Wu, R., & Hu, W. (2011) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjq040 · Cited by 232
“They can augment the oncogenic effect of the c-Myc and therefore function as an oncogene (He et al., 2005; Diosdado et al., 2009; Mu et al., 2009). miR-221 and miR-222 are frequently overexpressed in lung and liver cancers.”
BackgroundKoga, Y., Yasunaga, M., Takahashi, A., Kuroda, J., Moriya, Y., Akasu, T., Fujita, S., Yamamoto, S., Baba, H., & Matsumura, Y. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0036 · Cited by 216
Implication of microRNAs in drug resistance for designing novel cancer therapy
Sarkar, F. H., Li, Y., Wang, Z., Kong, D., & Ali, S. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.02.001 · Cited by 215
“The miR-17–92 cluster consisting of miR-17, miR-18a, miR-19a, miR-20a, miR-19b-1 and miR-92-1 also showed oncogenic activity in various cancers (Diosdado et al., 2009;He et al., 2005;Manni et al., 2009).”
BackgroundAllen, J., & Sears, C. L. (2019) · Genome Medicine · doi:10.1186/s13073-019-0621-2 · Cited by 204
“Early studies identified a correlation between increased expression of particular miRNAs and the proto-oncogene c-Myc [101].”
BackgroundLi, Y., Kong, D., Wang, Z., & Sarkar, F. H. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0105-y · Cited by 190
Identification and Evaluation of Plasma MicroRNAs for Early Detection of Colorectal Cancer
Luo, X., Stock, C., Burwinkel, B., & Brenner, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062880 · Cited by 177
MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer
Cekaite, L., Eide, P. W., Lind, G. E., Skotheim, R. I., & Lothe, R. A. (2016) · Oncotarget · doi:10.18632/oncotarget.6390 · Cited by 84
Koga (2011) · doi:10.3978/j.issn.2078-6891.2011.015
Metadata
- Authors
- Diosdado, B., van de Wiel, M. A., Terhaar Sive Droste, J. S., Mongera, S., Postma, C., Meijerink, W. J. H. J., Carvalho, B., & Meijer, G. A.
- Venue
- British Journal of Cancer
- Published
- 2009-08
- Volume
- 101
- Issue
- 4
- Pages
- 707-714
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2044782990
- Cited by
- 247
- References
- 10
- FWCI
- 6.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.